Toronto Dominion Bank
TARA icon

Toronto Dominion Bank’s Protara Therapeutics TARA Stock Holding History

Toronto Dominion Bank’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65K Buy
+12,470
New +$73.8K ﹤0.01% 1739
2025
Q1 		– Sell
-2,088,937
Closed -$11M – 1691
2024
Q4 		$11M Buy
+2,088,937
New +$6.75M 0.02% 504

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Toronto Dominion Bank's TARA Position: Q1 2026 in Review

Toronto Dominion Bank opened a new position in Protara Therapeutics (TARA) in Q1 2026: 12,470 shares worth $65K. The stake represents ﹤0.01% of the portfolio and ranks #1739 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in TARA as recently as Q4 2024.

Toronto Dominion Bank first reported a position in TARA in Q4 2024 and has held it in 2 quarters since. The position peaked at $11M in Q4 2024. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Toronto Dominion Bank held 12,470 shares of Protara Therapeutics worth $65K as of Q1 2026.
  • Protara Therapeutics was a new Toronto Dominion Bank position in Q1 2026.
  • Protara Therapeutics made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1739 holding.
  • Toronto Dominion Bank first reported a position in Protara Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • Toronto Dominion Bank's Protara Therapeutics position peaked at $11M in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.